nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—Granisetron—CYP1A1—polycystic ovary syndrome	0.00622	1	CrCbGaD
Hyoscyamine—Heartburn—Metformin—polycystic ovary syndrome	0.00164	0.0835	CcSEcCtD
Hyoscyamine—Blood disorder—Metformin—polycystic ovary syndrome	0.00135	0.0688	CcSEcCtD
Hyoscyamine—Nasal congestion—Metformin—polycystic ovary syndrome	0.000897	0.0458	CcSEcCtD
Hyoscyamine—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.000837	0.0428	CcSEcCtD
Hyoscyamine—Lethargy—Metformin—polycystic ovary syndrome	0.000834	0.0426	CcSEcCtD
Hyoscyamine—Dehydration—Metformin—polycystic ovary syndrome	0.00076	0.0388	CcSEcCtD
Hyoscyamine—Abdominal distension—Metformin—polycystic ovary syndrome	0.000711	0.0363	CcSEcCtD
Hyoscyamine—Angina pectoris—Metformin—polycystic ovary syndrome	0.000688	0.0351	CcSEcCtD
Hyoscyamine—Drowsiness—Metformin—polycystic ovary syndrome	0.00063	0.0322	CcSEcCtD
Hyoscyamine—Bradycardia—Metformin—polycystic ovary syndrome	0.000576	0.0294	CcSEcCtD
Hyoscyamine—Flushing—Metformin—polycystic ovary syndrome	0.000525	0.0268	CcSEcCtD
Hyoscyamine—Erythema—Metformin—polycystic ovary syndrome	0.000492	0.0251	CcSEcCtD
Hyoscyamine—Dysgeusia—Metformin—polycystic ovary syndrome	0.000482	0.0246	CcSEcCtD
Hyoscyamine—Vision blurred—Metformin—polycystic ovary syndrome	0.000464	0.0237	CcSEcCtD
Hyoscyamine—CHRM1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000459	0.000471	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000459	0.000471	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000458	0.00047	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000457	0.00047	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000457	0.00047	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000456	0.000468	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000453	0.000465	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000453	0.000465	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—STAR—polycystic ovary syndrome	0.000449	0.000461	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—FST—polycystic ovary syndrome	0.000444	0.000456	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000442	0.000454	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000442	0.000453	CbGpPWpGaD
Hyoscyamine—Syncope—Metformin—polycystic ovary syndrome	0.000441	0.0225	CcSEcCtD
Hyoscyamine—CHRM3—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000441	0.000452	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000439	0.00045	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000437	0.000448	CbGpPWpGaD
Hyoscyamine—Palpitations—Metformin—polycystic ovary syndrome	0.000435	0.0222	CcSEcCtD
Hyoscyamine—CHRM4—Signaling Pathways—LHB—polycystic ovary syndrome	0.000433	0.000445	CbGpPWpGaD
Hyoscyamine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000433	0.0221	CcSEcCtD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000432	0.000443	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000431	0.000442	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000429	0.000441	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000428	0.000439	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000426	0.000438	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000424	0.000435	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000424	0.000435	CbGpPWpGaD
Hyoscyamine—Chest pain—Metformin—polycystic ovary syndrome	0.000419	0.0214	CcSEcCtD
Hyoscyamine—CHRM1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000417	0.000428	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000415	0.000426	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000411	0.000422	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00041	0.000421	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000409	0.00042	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—SCT—polycystic ovary syndrome	0.000406	0.000417	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000405	0.000416	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000404	0.000415	CbGpPWpGaD
Hyoscyamine—Oedema—Metformin—polycystic ovary syndrome	0.000402	0.0205	CcSEcCtD
Hyoscyamine—CHRM4—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000401	0.000412	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—HMMR—polycystic ovary syndrome	0.0004	0.000411	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.0004	0.000411	CbGpPWpGaD
Hyoscyamine—Shock—Metformin—polycystic ovary syndrome	0.000395	0.0202	CcSEcCtD
Hyoscyamine—CHRM1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000395	0.000406	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000394	0.000404	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00039	0.0004	CbGpPWpGaD
Hyoscyamine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000388	0.0198	CcSEcCtD
Hyoscyamine—CHRM4—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000387	0.000398	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—HSD3B1—polycystic ovary syndrome	0.000382	0.000392	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000381	0.000391	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000378	0.000388	CbGpPWpGaD
Hyoscyamine—Hypotension—Metformin—polycystic ovary syndrome	0.000375	0.0192	CcSEcCtD
Hyoscyamine—CHRM4—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000372	0.000382	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000369	0.000379	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000368	0.000377	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000364	0.000374	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.00036	0.000369	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000359	0.000368	CbGpPWpGaD
Hyoscyamine—Dyspnoea—Metformin—polycystic ovary syndrome	0.000358	0.0183	CcSEcCtD
Hyoscyamine—Somnolence—Metformin—polycystic ovary syndrome	0.000357	0.0182	CcSEcCtD
Hyoscyamine—CHRM2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000355	0.000364	CbGpPWpGaD
Hyoscyamine—Dyspepsia—Metformin—polycystic ovary syndrome	0.000354	0.0181	CcSEcCtD
Hyoscyamine—CHRM4—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000352	0.000362	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—LHB—polycystic ovary syndrome	0.000348	0.000358	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000348	0.000357	CbGpPWpGaD
Hyoscyamine—Fatigue—Metformin—polycystic ovary syndrome	0.000346	0.0177	CcSEcCtD
Hyoscyamine—Constipation—Metformin—polycystic ovary syndrome	0.000343	0.0175	CcSEcCtD
Hyoscyamine—CHRM3—Metabolism—HSD3B2—polycystic ovary syndrome	0.000341	0.00035	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000336	0.000345	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000335	0.000344	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—INSR—polycystic ovary syndrome	0.000332	0.000341	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000332	0.00034	CbGpPWpGaD
Hyoscyamine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000331	0.0169	CcSEcCtD
Hyoscyamine—CHRM3—Metabolism—AKR1C1—polycystic ovary syndrome	0.00033	0.000339	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000329	0.000338	CbGpPWpGaD
Hyoscyamine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000328	0.0168	CcSEcCtD
Hyoscyamine—CHRM3—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000328	0.000337	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000327	0.000335	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000326	0.000334	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000325	0.000333	CbGpPWpGaD
Hyoscyamine—CHRM2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000323	0.000332	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000322	0.000331	CbGpPWpGaD
Hyoscyamine—Urticaria—Metformin—polycystic ovary syndrome	0.000319	0.0163	CcSEcCtD
Hyoscyamine—Abdominal pain—Metformin—polycystic ovary syndrome	0.000318	0.0162	CcSEcCtD
Hyoscyamine—CHRM4—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000316	0.000324	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000316	0.000324	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000315	0.000323	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000312	0.00032	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000311	0.000319	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PGR—polycystic ovary syndrome	0.000308	0.000316	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000307	0.000315	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000306	0.000314	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—SULT2A1—polycystic ovary syndrome	0.000303	0.000312	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000303	0.000311	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.000299	0.000307	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—FST—polycystic ovary syndrome	0.000298	0.000306	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000298	0.000306	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000297	0.000305	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000296	0.000304	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—FST—polycystic ovary syndrome	0.000296	0.000303	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000295	0.000303	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—RRM2—polycystic ovary syndrome	0.000294	0.000302	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000294	0.000302	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000292	0.0003	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000292	0.0003	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—LHB—polycystic ovary syndrome	0.000291	0.000299	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000288	0.000296	CbGpPWpGaD
Hyoscyamine—Asthenia—Metformin—polycystic ovary syndrome	0.000288	0.0147	CcSEcCtD
Hyoscyamine—CHRM4—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000286	0.000294	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000286	0.000294	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000286	0.000293	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000285	0.000292	CbGpPWpGaD
Hyoscyamine—Pruritus—Metformin—polycystic ovary syndrome	0.000284	0.0145	CcSEcCtD
Hyoscyamine—CHRM3—Metabolism—YAP1—polycystic ovary syndrome	0.000283	0.000291	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000282	0.000289	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000277	0.000284	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000276	0.000283	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000276	0.000283	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000276	0.000283	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000275	0.000282	CbGpPWpGaD
Hyoscyamine—Diarrhoea—Metformin—polycystic ovary syndrome	0.000275	0.014	CcSEcCtD
Hyoscyamine—CHRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000274	0.000281	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000273	0.00028	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000273	0.00028	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SCT—polycystic ovary syndrome	0.000273	0.00028	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000272	0.00028	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—NAMPT—polycystic ovary syndrome	0.000272	0.000279	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00027	0.000278	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SCT—polycystic ovary syndrome	0.00027	0.000277	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000269	0.000277	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CYP11A1—polycystic ovary syndrome	0.000269	0.000276	CbGpPWpGaD
Hyoscyamine—CHRM1—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000267	0.000275	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000267	0.000274	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000266	0.000273	CbGpPWpGaD
Hyoscyamine—Dizziness—Metformin—polycystic ovary syndrome	0.000266	0.0136	CcSEcCtD
Hyoscyamine—CHRM4—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000265	0.000272	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000261	0.000268	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00026	0.000267	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000258	0.000265	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000257	0.000264	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000256	0.000263	CbGpPWpGaD
Hyoscyamine—Vomiting—Metformin—polycystic ovary syndrome	0.000255	0.013	CcSEcCtD
Hyoscyamine—CHRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000255	0.000261	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—AKR1C3—polycystic ovary syndrome	0.000254	0.000261	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000254	0.00026	CbGpPWpGaD
Hyoscyamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000253	0.00026	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000253	0.00026	CbGpPWpGaD
Hyoscyamine—Rash—Metformin—polycystic ovary syndrome	0.000253	0.0129	CcSEcCtD
Hyoscyamine—Dermatitis—Metformin—polycystic ovary syndrome	0.000253	0.0129	CcSEcCtD
Hyoscyamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000253	0.000259	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000252	0.000259	CbGpPWpGaD
Hyoscyamine—Headache—Metformin—polycystic ovary syndrome	0.000252	0.0128	CcSEcCtD
Hyoscyamine—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000251	0.000258	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000251	0.000257	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—POMC—polycystic ovary syndrome	0.00025	0.000257	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CYP17A1—polycystic ovary syndrome	0.00025	0.000257	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00025	0.000257	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PRL—polycystic ovary syndrome	0.00025	0.000256	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000247	0.000254	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000241	0.000247	CbGpPWpGaD
Hyoscyamine—Nausea—Metformin—polycystic ovary syndrome	0.000239	0.0122	CcSEcCtD
Hyoscyamine—CHRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000238	0.000244	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000237	0.000243	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000237	0.000243	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000235	0.000241	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000234	0.000241	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000234	0.00024	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000231	0.000238	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000224	0.00023	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—INSR—polycystic ovary syndrome	0.000223	0.000229	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000221	0.000227	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—GNAS—polycystic ovary syndrome	0.00022	0.000225	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—TH—polycystic ovary syndrome	0.000216	0.000222	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000213	0.000219	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000212	0.000218	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—SLC2A4—polycystic ovary syndrome	0.00021	0.000216	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00021	0.000216	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00021	0.000215	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000209	0.000215	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000209	0.000215	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000208	0.000213	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000207	0.000212	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PGR—polycystic ovary syndrome	0.000207	0.000212	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000205	0.000211	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000205	0.00021	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CYP19A1—polycystic ovary syndrome	0.000198	0.000203	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000193	0.000198	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000193	0.000198	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000192	0.000197	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000192	0.000197	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00019	0.000195	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00019	0.000195	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000186	0.000191	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000185	0.00019	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000184	0.000189	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000183	0.000188	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000183	0.000188	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000182	0.000187	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000179	0.000184	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000179	0.000184	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000179	0.000183	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000178	0.000183	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000177	0.000182	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—GNAS—polycystic ovary syndrome	0.000177	0.000181	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000176	0.000181	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000176	0.000181	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—LEP—polycystic ovary syndrome	0.000172	0.000177	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.00017	0.000174	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000169	0.000174	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000169	0.000173	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000168	0.000173	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000168	0.000173	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—NCOR1—polycystic ovary syndrome	0.000168	0.000173	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PRL—polycystic ovary syndrome	0.000168	0.000172	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000168	0.000172	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000167	0.000171	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000166	0.000171	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000162	0.000167	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000162	0.000166	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.00016	0.000164	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.00016	0.000164	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CYP1A1—polycystic ovary syndrome	0.000159	0.000164	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000159	0.000163	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000158	0.000162	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000154	0.000158	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—MTHFR—polycystic ovary syndrome	0.000149	0.000153	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000148	0.000152	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—POMC—polycystic ovary syndrome	0.000148	0.000152	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000148	0.000152	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—INS—polycystic ovary syndrome	0.000147	0.000151	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000146	0.00015	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000142	0.000146	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000142	0.000146	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000141	0.000145	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000141	0.000144	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000139	0.000143	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000138	0.000142	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000138	0.000142	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000137	0.00014	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000135	0.000139	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PPARG—polycystic ovary syndrome	0.000121	0.000124	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—POMC—polycystic ovary syndrome	0.000119	0.000122	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000119	0.000122	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000118	0.000121	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—INS—polycystic ovary syndrome	0.000118	0.000121	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000117	0.00012	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000116	0.000119	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—LEP—polycystic ovary syndrome	0.000116	0.000119	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	0.000115	0.000118	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000109	0.000112	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000104	0.000106	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000103	0.000106	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000102	0.000105	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	9.97e-05	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—POMC—polycystic ovary syndrome	9.94e-05	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	9.92e-05	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—INS—polycystic ovary syndrome	9.88e-05	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	9.84e-05	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	9.79e-05	0.0001	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	9.59e-05	9.84e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	9.58e-05	9.84e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IGF1—polycystic ovary syndrome	9.56e-05	9.81e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AKT2—polycystic ovary syndrome	9.55e-05	9.81e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	9.47e-05	9.72e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	9.46e-05	9.71e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—VEGFA—polycystic ovary syndrome	9.29e-05	9.54e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.11e-05	9.35e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.08e-05	9.32e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.99e-05	9.23e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	7.33e-05	7.53e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—IL6—polycystic ovary syndrome	7.31e-05	7.5e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	7.24e-05	7.43e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IL6—polycystic ovary syndrome	6.43e-05	6.6e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.26e-05	6.43e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.24e-05	6.41e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.18e-05	6.35e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	4.33e-05	4.45e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IL6—polycystic ovary syndrome	4.32e-05	4.43e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	4.28e-05	4.39e-05	CbGpPWpGaD
